Asthma, Allergic
20
5
6
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
5.0%
1 terminated out of 20 trials
88.9%
+2.4% vs benchmark
30%
6 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (20)
Lung-Resident Memory Th2 Cells in Asthma
Dupilumab Effects Against Aeroallergen Challenge
IL13 Signaling in Allergic Asthma
Effects of Low Dose Ozone on Airway Inflammatory Responses in Adults With Asthma - Sedentary Nasal Ozone (Asthma SNOZ)
Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.
Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites
Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen
Plant Stanol Esters and Preventing Asthma Symptoms
Food-specific IgG4-guided Elimination Diets Improve Allergy Symptoms in Children
Biologics and Sublingual Immunotherapy
Tezepelumab and Methacholine Airway Hyperresponsiveness in Participants With Mild Allergic Asthma
Anakinra as a Rescue Treatment for Allergic Inflammation
Effects of Puressentiel Purifying Spray on Asthma Control in Patients With Mild to Moderate Allergy-induced Asthma.
Anti-IgE Monoclonal Antibody Treatment in Patients With Allergic Asthma.
Evaluating Asthma Exacerbation-induced Changes in Lung Function With a Home-based Spirometer
Study of REGN3500 and Dupilumab in Patients With Asthma
ICS Treatment Compliance of Asthma Patients
Identifying Serum Cytokine Profiles of Distinct Inflammatory Phenotypes in Severe Asthma
Effects of Intranasal Fluticasone Plus Azelastine on Airway Inflammation in Patients With Asthma & Allergic Rhinitis
Validation of Proteomic Analyses for Allergic Asthma and Rhinitis